PICARSA

What this means for you

This application is over — abandoned 08 Apr 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

85374134

Mark type

Stylized text

Filed

18 Jul 2011

Published for opposition

10 Jul 2012

Abandoned

08 Apr 2013

Attorney of record

Anne H. Peck

Goods and services

• Class 005 — Pharmaceuticals: Human and veterinary pharmaceuticals for use in the prevention and treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
• Class 042 — Scientific and technological services: Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases

Owner

• Onyx Pharmaceuticals, Inc., South San Francisco, CA, US
• Onyx Pharmaceuticals, Inc., South San Francisco, CA, US

Prosecution history

• 08 Apr 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
• 08 Apr 2013 — ABANDONMENT - NO USE STATEMENT FILED
• 04 Sept 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 10 Jul 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Jul 2012 — PUBLISHED FOR OPPOSITION
• 20 Jun 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 04 Jun 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
• 04 Jun 2012 — ASSIGNED TO LIE
• 15 May 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 16 Mar 2012 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 15 Mar 2012 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 15 Mar 2012 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 16 Sept 2011 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 16 Sept 2011 — NON-FINAL ACTION E-MAILED
• 16 Sept 2011 — NON-FINAL ACTION WRITTEN